ARMATA PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2021-03-18
- ARMATA PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2020 was 0.00%.
- ARMATA PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2019 was -3.10%.
- ARMATA PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2018 was -20.30%.
- ARMATA PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2016 was -13.20%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2020-12-31 | 0.00% 10-K · filed 2021-03-18 |
| 2019-12-31 | -3.10% 10-K · filed 2021-03-18 |
| 2018-12-31 | -20.30% 10-K · filed 2019-03-25 |
| 2016-12-31 | -13.20% 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |